1. Comparison of high-dose and low-dose corticosteroid therapy for refractory Mycoplasma pneumoniae pneumonia in children
- Author
-
Shotaro Ando, Takashi Kawabe, Kei Ikeda, Maki Kato, Michio Suzuki, Yuichiro Sugiyama, Shinji Hasegawa, Nobuhiro Watanabe, Kazuhisa Naruse, Jun-ichi Kawada, Yoshiyuki Takahashi, Yuji Hirayama, Yuji Miyajima, Marei Omori, Noriko Nagai, Yoshihiro Nagata, Satoru Doi, Tomonori Ishiguro, Kotaro Narita, Motohiro Shibata, Ryosuke Suzui, Shinji Kido, Mitsuharu Kajita, Sho Narahara, Toshihiko Okumura, Shin Hoshino, Takuto Ito, Masahiro Nakatochi, Daichi Fukumi, Genki Tsuji, Nozomi Uno, Takeshi Tsuji, Yuma Takahashi, Masaharu Tanaka, Noriko Tokumo, Masashi Morishita, Hiroyuki Takada, Hideki Muramatsu, Koji Kato, Hiroyuki Kidokoro, Yuji Sudo, Yoshiaki Sato, and Yusuke Shibata
- Subjects
Male ,0301 basic medicine ,Microbiology (medical) ,Refractory pneumonia ,medicine.medical_specialty ,Time Factors ,Fever ,Mycoplasma pneumoniae pneumonia ,medicine.drug_class ,030106 microbiology ,Disease ,03 medical and health sciences ,0302 clinical medicine ,Refractory ,Internal medicine ,Drug Resistance, Bacterial ,Pneumonia, Mycoplasma ,medicine ,Humans ,Corticosteroids ,Pharmacology (medical) ,030212 general & internal medicine ,Child ,Adverse effect ,Glucocorticoids ,Retrospective Studies ,Dose-Response Relationship, Drug ,business.industry ,Length of Stay ,medicine.disease ,Mycoplasma pneumoniae ,Pneumonia ,Treatment Outcome ,Infectious Diseases ,Child, Preschool ,Propensity score matching ,Prednisolone ,Corticosteroid ,Female ,business ,medicine.drug - Abstract
Background: Mycoplasma pneumoniae pneumonia (MPP) is generally a self-limiting disease, but it may become refractory. It is thought that refractory MPP is linked to the excessive immunologic responses of the host. Consequently, the use of adjunctive systemic corticosteroids may have beneficial effects. In this study, we compared the effects of high- and low-dose corticosteroid therapy in a pediatric population with refractory MPP. Methods: We retrospectively collected data from 91 pediatric MPP patients treated with adjunctive systemic corticosteroids between April 2014 and October 2016. The patients were divided into the following two groups: high-dose corticosteroid group (2 mg/kg/day or more of prednisolone equivalents; n = 38) and low-dose corticosteroid group (, ファイル公開:2020-05-01
- Published
- 2019